BROYDRICK & ASSOCIATES

Lobbying for TONIX PHARMACEUTICALS · Pharmaceutical development and manufacturing.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $20,000.00 income · posted Jan 12, 2026

Lobbying activity 1

Pharmacy

Funding new drug for PTSD and COVID 19, BARDA appropriations.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem